GB1320076A - Therapeutic compositions containing 3-4-biphenylcarbonyl propionic acid - Google Patents

Therapeutic compositions containing 3-4-biphenylcarbonyl propionic acid

Info

Publication number
GB1320076A
GB1320076A GB3150771A GB3150771A GB1320076A GB 1320076 A GB1320076 A GB 1320076A GB 3150771 A GB3150771 A GB 3150771A GB 3150771 A GB3150771 A GB 3150771A GB 1320076 A GB1320076 A GB 1320076A
Authority
GB
United Kingdom
Prior art keywords
biphenylcarbonyl
propionic acid
therapeutic compositions
compositions containing
pharmaceutically acceptable
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
GB3150771A
Other languages
English (en)
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Wyeth Holdings LLC
Original Assignee
American Cyanamid Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=22117783&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=GB1320076(A) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by American Cyanamid Co filed Critical American Cyanamid Co
Publication of GB1320076A publication Critical patent/GB1320076A/en
Expired legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C59/00—Compounds having carboxyl groups bound to acyclic carbon atoms and containing any of the groups OH, O—metal, —CHO, keto, ether, groups, groups, or groups
    • C07C59/40—Unsaturated compounds
    • C07C59/76—Unsaturated compounds containing keto groups
    • C07C59/90—Unsaturated compounds containing keto groups containing singly bound oxygen-containing groups
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C323/00—Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C59/00—Compounds having carboxyl groups bound to acyclic carbon atoms and containing any of the groups OH, O—metal, —CHO, keto, ether, groups, groups, or groups
    • C07C59/40—Unsaturated compounds
    • C07C59/76—Unsaturated compounds containing keto groups
    • C07C59/84—Unsaturated compounds containing keto groups containing six membered aromatic rings

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
GB3150771A 1970-09-21 1971-07-05 Therapeutic compositions containing 3-4-biphenylcarbonyl propionic acid Expired GB1320076A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US7410870A 1970-09-21 1970-09-21

Publications (1)

Publication Number Publication Date
GB1320076A true GB1320076A (en) 1973-06-13

Family

ID=22117783

Family Applications (1)

Application Number Title Priority Date Filing Date
GB3150771A Expired GB1320076A (en) 1970-09-21 1971-07-05 Therapeutic compositions containing 3-4-biphenylcarbonyl propionic acid

Country Status (11)

Country Link
US (1) US3784701A (enExample)
BE (1) BE772804A (enExample)
CA (1) CA994242A (enExample)
DE (1) DE2147111C3 (enExample)
ES (1) ES9000032A1 (enExample)
FR (1) FR2107848B1 (enExample)
GB (1) GB1320076A (enExample)
IL (1) IL37637A (enExample)
MY (1) MY7500135A (enExample)
NL (1) NL175788C (enExample)
ZA (1) ZA714252B (enExample)

Families Citing this family (26)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4008323A (en) * 1974-03-25 1977-02-15 Pierre Fabre S.A. Method of reducing cholesterol using certain aromatic keto acids
US3966960A (en) * 1975-04-25 1976-06-29 American Cyanamid Company 3-(4-Biphenylcarbonyl)propionic acid as an inhibitor of platelet aggregation
US4247466A (en) * 1979-07-05 1981-01-27 American Cyanamid Company Lactone metabolites of 3-(4-biphenylylcarbonyl)propionic acid
US4782089A (en) * 1986-08-26 1988-11-01 A. H. Robins Company, Incorporated 2-amino-3-aroyl-gamma-oxobenzenebutanoic acids and esters
US5280045A (en) * 1991-10-16 1994-01-18 The Procter & Gamble Company 4(3,5-bis(1,1-dimethylethyl-4-hydroxyphenyl)-4-oxobutanamide compound useful as an anti-inflammatory agent
US5789434A (en) * 1994-11-15 1998-08-04 Bayer Corporation Derivatives of substituted 4-biarylbutyric acid as matrix metalloprotease inhibitors
IL115995A0 (en) * 1994-11-15 1996-01-31 Bayer Ag Substituted 4-biarylbutyric or 5-biarylpentanoic acids and derivatives as matrix metalloprotease inhibitors
US5886022A (en) * 1995-06-05 1999-03-23 Bayer Corporation Substituted cycloalkanecarboxylic acid derivatives as matrix metalloprotease inhibitors
US5684204A (en) * 1995-11-15 1997-11-04 The Procter & Gamble Company Sulfur containing di-tert-butylphenol compounds useful as anti-inflammatory agents
US6919375B1 (en) 1996-01-23 2005-07-19 Shionogi & Co., Ltd. Sulfonated amino acid derivatives and metalloproteinase inhibitors containing the same
KR100338857B1 (ko) 1996-01-23 2002-05-30 시오노 요시히코 술폰화 아미노산 유도체 및 이를 함유한메탈로프로테이나제 저해제
HRP970245B1 (en) * 1996-05-15 2002-06-30 Bayer Ag Biaryl acetilenes as matrix metalloprotease inhibitors
US5968795A (en) * 1996-05-15 1999-10-19 Bayer Corporation Biaryl acetylenes as inhibitors of matrix metalloproteases
CO5070565A1 (es) * 1996-05-15 2001-08-28 Bayer Corp Inhibicion de las metaloproteasas de matriz por compuestos de fenetilo sustituido y sus composiciones farmaceuticas
IT1288123B1 (it) * 1996-09-04 1998-09-10 Nicox Sa Uso di nitroderivati per l'incontinenza urinaria
SI0946166T1 (en) * 1996-12-17 2004-06-30 Warner-Lambert Company Llc Use of matrix metalloproteinase inhibitors for promoting wound healing
US6340709B1 (en) 1996-12-17 2002-01-22 Warner-Lambert Company Use of matrix metalloproteinase inhibitors for treating neurological disorders and promoting wound healing
US5756545A (en) * 1997-04-21 1998-05-26 Warner-Lambert Company Biphenysulfonamide matrix metal alloproteinase inhibitors
IT1308633B1 (it) 1999-03-02 2002-01-09 Nicox Sa Nitrossiderivati.
IT1318674B1 (it) * 2000-08-08 2003-08-27 Nicox Sa Faramaci per l'incontinenza.
IT1318673B1 (it) * 2000-08-08 2003-08-27 Nicox Sa Farmaci per le disfunzioni sessuali.
FR2832925B1 (fr) * 2001-12-03 2006-07-14 Lipha Utilisation de derives de l'acide 4-oxobutanoique dans le traitement de l'inflammation
ITMI20020773A1 (it) * 2002-04-11 2003-10-13 Nicox Sa Farmaci per il trattamento dell'artrite
US20040234701A1 (en) * 2003-02-19 2004-11-25 Caton Gregory James Lower alkyl carboxylic acid moieties as organoleptic stabilizers and preservatives of food and beverages and for preventing oxidative corrosion of metals
ES2586423T3 (es) * 2004-05-14 2016-10-14 Emisphere Technologies, Inc. Compuestos de aril cetona y composiciones para administrar principios activos
WO2010118435A2 (en) 2009-04-10 2010-10-14 Tufts Medical Center, Inc. Par-1 activation by metalloproteinase-1 (mmp-1)

Also Published As

Publication number Publication date
NL7110996A (enExample) 1972-03-23
BE772804A (fr) 1972-03-20
DE2147111C3 (de) 1980-01-31
ES395257A0 (es) 1975-01-01
ES9000032A1 (es) 1975-01-01
IL37637A0 (en) 1971-11-29
NL175788C (nl) 1985-01-02
NL175788B (nl) 1984-08-01
FR2107848B1 (enExample) 1975-08-01
DE2147111A1 (de) 1972-03-23
FR2107848A1 (enExample) 1972-05-12
DE2147111B2 (de) 1979-05-10
CA994242A (en) 1976-08-03
IL37637A (en) 1974-06-30
MY7500135A (en) 1975-12-31
US3784701A (en) 1974-01-08
ZA714252B (en) 1972-03-29

Similar Documents

Publication Publication Date Title
GB1320076A (en) Therapeutic compositions containing 3-4-biphenylcarbonyl propionic acid
GB940596A (en) ª -hydrazino acids
PT66271A (en) Process for the preparation of a parasiticidal composition containing 4,5-dichloroimidazole-2-carboxilic acid derivatives and salts thereof
CA973554A (en) 2,3,5,6-tetraaminopyridine and its acid salts and processes for its preparation
GB1301973A (enExample)
GB1436487A (en) Compositions for oral hygiene
GB1455049A (en) Process for the manufacture of 3- 3,4-dihydroxy-phenyl-serine
ES444948A1 (es) Un procedimiento para la separacion de impurezas contaminan-tes del acido clavulanico.
GB1402691A (en) Composition of 4-biphenyl acetic acid
CA1020941A (en) Substituted 2-phenylamino-imidazolines-(2), the acid addition salts thereof, pharmaceuticals containing same and processes for production thereof
GB1378068A (en) Citric acid derivatives
AU472024B2 (en) l-(3-CYANO-3, 3, DIPHENYLPROPYL)-4-PEHNYLPIP ERINE-4-CARBOXYLIC ACID DERIVATIVES
ES8302623A1 (es) "procedimiento para la preparacion del acido (2',4'-difluoro-4-bifenil)-oxipropionico".
GB1187946A (en) Dimethylbiguanide Derivative
GB1280386A (en) Anti-fertility agents
GB1359560A (en) Preparation of pyrrylsalicylic acid
GB1394757A (en) Lysino-calcium chloride
GB1246117A (en) Pharmaceutical preparations containing glucose compounds, glucose derivatives and process for their manufacture
GB1259264A (enExample)
FR2321467A1 (fr) Procede pour la preparation d'un compose polyenique contenant un groupement 3,7-dimethyl-nona-1,3,5,7-tetraen-1-yle
GB1260939A (en) beta-HYDRAZINO-ALKANOIC ACIDS AND PROCESSES FOR THEIR PREPARATION
GB1252540A (enExample)
GB1356991A (en) Kanamycin a salts
IE33519B1 (en) Novel benzyl-hydrazide derivatives and a process for the manufacture thereof and novel benzylidene-hydrazide derivatives useful in said process
GB1287506A (en) Arginine-potassium phosphocitro-glutamate

Legal Events

Date Code Title Description
PS Patent sealed [section 19, patents act 1949]
746B Proceeding under section 46(3) patents act 1977
746B Proceeding under section 46(3) patents act 1977
746B Proceeding under section 46(3) patents act 1977
746B Proceeding under section 46(3) patents act 1977
746B Proceeding under section 46(3) patents act 1977
746B Proceeding under section 46(3) patents act 1977
746B Proceeding under section 46(3) patents act 1977
746B Proceeding under section 46(3) patents act 1977
746B Proceeding under section 46(3) patents act 1977
746B Proceeding under section 46(3) patents act 1977
746B Proceeding under section 46(3) patents act 1977
746B Proceeding under section 46(3) patents act 1977
746B Proceeding under section 46(3) patents act 1977
746D Case decided by the comptroller (sect. 46(3)/1977)
PE20 Patent expired after termination of 20 years